Publications by authors named "Zehra Sarıgoel Kılıc"
Introduction: This study aimed to assess the incidence of hematologic malignancy (HM) among inflammatory arthritis (IA) patients receiving tumor necrosis factor inhibitors (TNFi) compared with the general Turkish population.
Methods: HUR-BIO (Hacettepe University Rheumatology Biologic Registry) is a single-center biological disease-modifying anti-rheumatic drug (bDMARD) registry since 2005. Patients with IA, including rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis who had at least one visit after the TNFi were screened from 2005 to November 2021.
Article Synopsis
- The study evaluated the mortality rates of patients with Psoriatic Arthritis (PsA) before and during the COVID-19 pandemic by analyzing data from a Turkish registry linked to the Cause of Death Registry.
- Findings revealed that the crude mortality rate in PsA patients doubled during the pandemic, with noticeable increases in both genders but more significant in females.
- The research concluded that pre-pandemic mortality rates for PsA were similar to the general population, but the pandemic has raised concerns about a potential increased mortality risk for PsA patients due to COVID-19, warranting further investigation.